NuVasive Inc.'s share price took a beating last week after the company lowered its 2010 sales and earnings guidance and lost a trademark infringement case to the tune of $60 million.
Shares of NuVasive Inc. (NSDQ:NUVA) plunged nearly 30 percent after the company lowered its guidance and suffered a legal setback last week.
The San Diego-based medical device maker, citing lower-than-expected spinal procedure numbers, cut its full-year guidance from sales of $485 million to $495 million to $470 to $495 million, down 3.1 percent on the lower end. Earning per share are now expected to be between $1.61 and $1.64, down 9 percent to 12 percent from $1.77 to $1.87.
Covidien’s 3-year study results showing positive outcomes for its Urgent PC Neuromodulation system in...
NEC Display Solutions wins 510(k) clearance for its 21-inch medical monitor systems.
J&J's former head of global cardiology makes the jump to CEO at Itamar Medical
Sunshine Heart raises $1.5 million of a hoped-for $25.5 million equity funding round.
J&J subsidiary Lifescan asks the courts to ban Shasta from using its logo, saying problems with...